ANNOUNCEMENT

Take a look at the MedCity ENGAGE program, with expert speakers from leading organizations. Reserve your place today.

Topic: pharmaceuticals

Asthma drug slashes episodes by 87% in mid-stage trial

Asthma drug slashes episodes by 87% in mid-stage trial

May 21, 2013 8:16 am by | 0 Comments

May 21 (Reuters) - A new type of asthma drug meant to attack the underlying causes of the respiratory disease slashed episodes by 87 percent in a mid-stage trial, making ... Read more
Pfizer halts study of inotuzumab ozogamicin for lymphoma

Pfizer halts study of inotuzumab ozogamicin for lymphoma

May 20, 2013 5:47 pm by | 0 Comments

(Reuters) - Pfizer Inc, which has been on a hot streak with three recent approvals of cancer drugs, stumbled on Monday, saying it was halting a late-stage trial of a ... Read more
PatientsLikeMe opens health outcomes measurement hub for researcher-patient collaboration

PatientsLikeMe opens health outcomes measurement hub for researcher-patient collaboration

May 20, 2013 4:49 pm by | 0 Comments

As part of its efforts to give patients a stronger voice in clinical trial design, PatientsLikeMe has opened up a hub where researchers, clinicians, academics and patients can refine and ... Read more
Anticancer drug developer Karyopharm raises more than $48M in series B round

Anticancer drug developer Karyopharm raises more than $48M in series B round

May 20, 2013 10:47 am by | 0 Comments

Biotechnology company Karyopharm Therapeutics has raised $48.2 million in a series B round for an innovative group of molecules to combat cancer, according to a company statement.Karyopharm’s approach, in phase ... Read more
Lundbeck: Trial shows Vortioxetine is safe and eases depression symptoms

Lundbeck: Trial shows Vortioxetine is safe and eases depression symptoms

May 18, 2013 2:05 pm by | 0 Comments

COPENHAGEN (Reuters) - Danish pharmaceutical group Lundbeck and Japanese partner Takeda said on Saturday that data from clinical phase III studies with the antidepressant vortioxetine had shown significant improvement in ... Read more
Wow of the week: Scientists use layered clay to grow bone cells

Wow of the week: Scientists use layered clay to grow bone cells

May 18, 2013 8:15 am by | 0 Comments

It was a big news for stem cells this week, particularly from a group of researchers who successfully transformed human skin cells into embryonic stem cells, showing that it’s possible ... Read more
Biotech, meet service provider. This startup strives to streamline the process of outsourcing

Biotech, meet service provider. This startup strives to streamline the process of outsourcing

May 17, 2013 11:26 am by | 1 Comments

The “virtual” business models that have become common in many biotech startups may allow companies to operate with less capital, but they also present their own set of challenges.One of ... Read more
Source reveals Sweden’s Recipharm is seeking advice on a partial sale or listing

Source reveals Sweden’s Recipharm is seeking advice on a partial sale or listing

May 16, 2013 12:00 pm by | 0 Comments

STOCKHOLM (Reuters) - Sweden's Recipharm has hired UBS to advise on either a partial sale of the pharmaceutical company or a listing on the Stockholm exchange, a source close to ... Read more
With a band of biotech collaborators, RuiYi sets sail developing new biologic drugs for China

With a band of biotech collaborators, RuiYi sets sail developing new biologic drugs for China

May 16, 2013 9:37 am by | 0 Comments

The La Jolla, California, biotech formerly known as Anaphore is looking a little different these days. Under the leadership of former Fate Therapeutics CEO Paul Grayson, Anaphore changed its name ... Read more
Combo therapy of Yervoy + Nivolumab shrank tumors in 75% of melanoma patients

Combo therapy of Yervoy + Nivolumab shrank tumors in 75% of melanoma patients

May 15, 2013 6:24 pm by | 1 Comments

CHICAGO (Reuters) - Melanoma patients treated with two Bristol-Myers Squibb drugs fared much better than those who received either of the medications individually, a new advance for treatments that harness ... Read more
Experimental Gilead drug stalls leukemia for 17 months in early trial

Experimental Gilead drug stalls leukemia for 17 months in early trial

May 15, 2013 6:12 pm by | 0 Comments

(Reuters) - An experimental drug from Gilead Sciences Inc shrank tumors in half of leukemia patients whose cancer had returned, according to an early-stage trial that represents a new foray ... Read more
J&J’s wins ulcerative colitis indication for Simponi

J&J’s wins ulcerative colitis indication for Simponi

May 15, 2013 5:55 pm by | 0 Comments

(Reuters) - The Food and Drug Administration has approved Johnson & Johnson's drug Simponi for patients with moderate to severe ulcerative colitis, an inflammatory disease affecting the colon.Simponi is already ... Read more
Roche banks on new drug data to defend cancer business

Roche banks on new drug data to defend cancer business

May 15, 2013 1:00 am by | 0 Comments

ZURICH (Reuters) - Swiss drugmaker Roche hopes data published this week will show it has a viable follow-on product to help fend off cheaper competition for its best-selling cancer drug, ... Read more
Are biosimilars ethical?

Are biosimilars ethical?

May 14, 2013 7:47 pm by | 0 Comments

Generic drugs have been an effective cost containment solution for traditional, small molecule pharmaceuticals. As large molecule biologics proliferate and take up a growing share of medical spending, we also ... Read more
Sanofi taps PatientsLikeMe to spur clinical trial participation

Sanofi taps PatientsLikeMe to spur clinical trial participation

May 14, 2013 7:07 pm by | 0 Comments

It’s no secret that drug developers have had a tough time recruiting clinical trial participants. Companies are trying a myriad of approaches to help pharmaceutical companies solve this challenge from ... Read more